Operaciones Genprex, Inc. - GNPX CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Diferencial | 0.0410 | ||||||||
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.025457% | ||||||||
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | 0.003235% | ||||||||
Horario tarifa nocturna | 21:00 (UTC) | ||||||||
Cantidad comercializada mínima | 1 | ||||||||
Divisa | USD | ||||||||
Margen | 20% | ||||||||
Mercado de valores | United States of America | ||||||||
Comisión por operación | 0% |
*Information provided by Capital.com
Genprex Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Cierre previo* | 0.868 |
Abrir* | 0.8856 |
Cambio de 1 año* | -39.34% |
Rango del día* | 0.7858 - 0.8944 |
Rango de 52 semanas | 0.72-2.67 |
Volumen medio (10 días) | 271.17K |
Volumen medio (3 meses) | 9.79M |
Capitalización de mercado | 46.26M |
Ratio P/E | -100.00K |
Acciones en circulación | 51.98M |
Ingresos | N/A |
EPS | -0.56 |
Dividendo (Rendimiento %) | N/A |
Beta | -0.32 |
Próxima fecha de resultados | N/A |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Cierre | Change | Change (%) | Apertura | High | Low |
---|---|---|---|---|---|---|
May 30, 2023 | 0.7874 | -0.0971 | -10.98% | 0.8845 | 0.9043 | 0.7682 |
May 26, 2023 | 0.8680 | -0.0075 | -0.86% | 0.8755 | 0.9329 | 0.8560 |
May 25, 2023 | 0.8333 | 0.0780 | 10.33% | 0.7553 | 0.8447 | 0.7383 |
May 24, 2023 | 0.7601 | 0.0019 | 0.25% | 0.7582 | 0.7769 | 0.7532 |
May 23, 2023 | 0.7664 | 0.0032 | 0.42% | 0.7632 | 0.7796 | 0.7568 |
May 22, 2023 | 0.7664 | 0.0182 | 2.43% | 0.7482 | 0.7856 | 0.7336 |
May 19, 2023 | 0.7544 | -0.0038 | -0.50% | 0.7582 | 0.7751 | 0.7441 |
May 18, 2023 | 0.7554 | 0.0121 | 1.63% | 0.7433 | 0.7559 | 0.7271 |
May 17, 2023 | 0.7530 | -0.0221 | -2.85% | 0.7751 | 0.7851 | 0.7155 |
May 16, 2023 | 0.7801 | -0.0148 | -1.86% | 0.7949 | 0.7988 | 0.7552 |
May 15, 2023 | 0.7951 | -0.0010 | -0.13% | 0.7961 | 0.8095 | 0.7890 |
May 12, 2023 | 0.8063 | 0.0081 | 1.01% | 0.7982 | 0.8220 | 0.7841 |
May 11, 2023 | 0.8016 | 0.0035 | 0.44% | 0.7981 | 0.8141 | 0.7981 |
May 10, 2023 | 0.7981 | 0.0000 | 0.00% | 0.7981 | 0.8218 | 0.7981 |
May 9, 2023 | 0.7989 | 0.0008 | 0.10% | 0.7981 | 0.8134 | 0.7777 |
May 8, 2023 | 0.7945 | -0.0071 | -0.89% | 0.8016 | 0.8102 | 0.7648 |
May 5, 2023 | 0.7936 | 0.0175 | 2.25% | 0.7761 | 0.8145 | 0.7626 |
May 4, 2023 | 0.7683 | -0.0276 | -3.47% | 0.7959 | 0.8181 | 0.7657 |
May 3, 2023 | 0.7947 | 0.0196 | 2.53% | 0.7751 | 0.8336 | 0.7680 |
May 2, 2023 | 0.7626 | 0.0084 | 1.11% | 0.7542 | 0.7979 | 0.7482 |
Genprex, Inc. Events
Hora (UTC) (UTC) | País | Evento |
---|---|---|
Friday, June 23, 2023 | ||
Hora (UTC) (UTC) 14:00 | País US
| Evento Genprex Inc Annual Shareholders Meeting Genprex Inc Annual Shareholders MeetingForecast -Previous - |
Tuesday, June 27, 2023 | ||
Hora (UTC) (UTC) 14:00 | País US
| Evento Genprex Inc Annual Shareholders Meeting Genprex Inc Annual Shareholders MeetingForecast -Previous - |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 | 0 |
Ingresos | 0 | 0 | 0 | 0 | 0 |
Gastos totales de explotación | 23.8307 | 20.6701 | 17.9616 | 10.6827 | 12.3635 |
Gastos de venta/general/administración Gastos, total | 12.2951 | 11.6767 | 10.6359 | 8.7026 | 11.3862 |
Investigación y desarrollo | 11.5101 | 8.97087 | 7.30292 | 1.96701 | 0.97143 |
Depreciation / Amortization | 0.02558 | 0.02253 | 0.02278 | 0.01307 | 0.00589 |
Ingresos de explotación | -23.8307 | -20.6701 | -17.9616 | -10.6827 | -12.3635 |
Ingresos netos antes de impuestos | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Ingresos netos después de impuestos | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Beneficio neto antes de partidas extra. Elementos | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Ingresos netos | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Ajuste por dilución | |||||
Beneficio neto diluido | -23.7406 | -20.665 | -17.9428 | -10.6548 | -12.3723 |
Promedio ponderado de acciones diluidas | 47.9521 | 47.0973 | 35.5229 | 16.027 | 13.771 |
BPA diluido sin partidas extraordinarias | -0.49509 | -0.43877 | -0.5051 | -0.6648 | -0.89843 |
Dividends per Share - Common Stock Primary Issue | |||||
BPA normalizado diluido | -0.49509 | -0.43877 | -0.5051 | -0.6648 | -0.89843 |
Ingresos por intereses (gastos), netos No operativos | 0.0901 | 0.00513 | 0.01881 | 0.02791 | -0.0088 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Ingresos totales | 0 | 0 | 0 | 0 | 0 |
Ingresos | 0 | 0 | 0 | ||
Gastos totales de explotación | 9.27125 | 6.82163 | 6.11065 | 5.17507 | 5.3107 |
Gastos de venta/general/administración Gastos, total | 3.95708 | 3.49665 | 2.51112 | 2.4315 | 3.26374 |
Investigación y desarrollo | 5.31015 | 3.3189 | 3.59331 | 2.73703 | 2.04023 |
Depreciation / Amortization | 0.00402 | 0.00608 | 0.00622 | 0.00654 | 0.00673 |
Ingresos de explotación | -9.27125 | -6.82163 | -6.11065 | -5.17507 | -5.3107 |
Ingresos por intereses (gastos), netos No operativos | 0.06847 | 0.0556 | 0.02788 | 0.00574 | 0.00088 |
Ingresos netos antes de impuestos | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Ingresos netos después de impuestos | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Beneficio neto antes de partidas extra. Elementos | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Ingresos netos | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Beneficio neto diluido | -9.20277 | -6.76603 | -6.08278 | -5.16933 | -5.30982 |
Promedio ponderado de acciones diluidas | 49.4716 | 48.0495 | 47.9847 | 47.8934 | 47.8796 |
BPA diluido sin partidas extraordinarias | -0.18602 | -0.14081 | -0.12676 | -0.10793 | -0.1109 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
BPA normalizado diluido | -0.18602 | -0.14081 | -0.12676 | -0.10793 | -0.1109 |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Activo Corriente | 21.4732 | 39.1402 | 27.7044 | 2.97664 | 8.84707 |
Efectivo e inversiones a corto plazo | 20.9541 | 38.6289 | 27.3197 | 2.00249 | 8.60092 |
Cash | 20.9541 | 38.6289 | 27.3197 | 2.00249 | 8.60092 |
Prepaid Expenses | 0.48422 | 0.51135 | 0.38455 | 0.17172 | 0.23685 |
Total Assets | 25.085 | 42.8623 | 31.3672 | 3.53423 | 9.26896 |
Property/Plant/Equipment, Total - Net | 0.02303 | 0.04861 | 0.03944 | 0.04465 | 0.02435 |
Intangibles, Net | 3.56703 | 3.66476 | 3.61267 | 0.4912 | 0.37945 |
Other Long Term Assets, Total | 0.02182 | 0.00869 | 0.01074 | 0.02173 | 0.01809 |
Total Current Liabilities | 2.81029 | 1.5853 | 0.45072 | 0.51068 | 0.38782 |
Accounts Payable | 0.44293 | 0.9732 | 0.19297 | 0.43626 | 0.29507 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0.07443 | 0.09275 |
Total Liabilities | 2.81029 | 1.5853 | 0.45072 | 0.51068 | 0.38782 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 22.2747 | 41.277 | 30.9165 | 3.02355 | 8.88114 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.04811 | 0.04787 | 0.04312 | 0.01926 | 0.01524 |
Additional Paid-In Capital | 125.054 | 119.247 | 89.2956 | 43.4837 | 38.6906 |
Retained Earnings (Accumulated Deficit) | -102.828 | -78.0179 | -58.4222 | -40.4795 | -29.8247 |
Total Liabilities & Shareholders’ Equity | 25.085 | 42.8623 | 31.3672 | 3.53423 | 9.26896 |
Total Common Shares Outstanding | 48.106 | 47.8747 | 43.1177 | 19.2638 | 15.2392 |
Total deudores, neto | 0.03485 | 0 | 0.00013 | 0.00066 | 0.0093 |
Accounts Receivable - Trade, Net | 0.03485 | 0 | 0.00013 | 0.00066 | 0.0093 |
Total Inventory | 0.80178 | ||||
Other Current Liabilities, Total | 2.36736 | 0.6121 | 0.25776 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Activo Corriente | 19.9421 | 21.4732 | 26.3082 | 30.9008 | 35.7031 |
Efectivo e inversiones a corto plazo | 18.0828 | 20.9541 | 25.5161 | 30.053 | 34.5553 |
Cash | 18.0828 | 20.9541 | 25.5161 | 30.053 | 34.5553 |
Total deudores, neto | 0 | 0.03485 | 0.03485 | 0.03217 | |
Accounts Receivable - Trade, Net | 0 | 0.03485 | 0.03485 | 0.03217 | |
Total Inventory | |||||
Prepaid Expenses | 1.85934 | 0.48422 | 0.75728 | 0.8478 | 1.1156 |
Total Assets | 23.3201 | 25.085 | 29.9458 | 34.5651 | 39.4094 |
Property/Plant/Equipment, Total - Net | 0.01902 | 0.02303 | 0.02911 | 0.03533 | 0.04188 |
Intangibles, Net | 3.33712 | 3.56703 | 3.58671 | 3.61897 | 3.65444 |
Other Long Term Assets, Total | 0.02182 | 0.02182 | 0.02182 | 0.01 | 0.01 |
Total Current Liabilities | 4.83522 | 2.81029 | 2.45731 | 2.15384 | 2.38482 |
Accounts Payable | 2.21225 | 0.44293 | 0.68387 | 0.68332 | 1.25298 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 2.62296 | 2.36736 | 1.77344 | 1.47052 | 1.13184 |
Total Liabilities | 4.83522 | 2.81029 | 2.45731 | 2.15384 | 2.38482 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 18.4849 | 22.2747 | 27.4885 | 32.4113 | 37.0246 |
Common Stock | 0.05197 | 0.04811 | 0.04802 | 0.0479 | 0.04788 |
Additional Paid-In Capital | 130.463 | 125.054 | 122.433 | 121.273 | 120.717 |
Retained Earnings (Accumulated Deficit) | -112.031 | -102.828 | -94.9924 | -88.9097 | -83.7403 |
Total Liabilities & Shareholders’ Equity | 23.3201 | 25.085 | 29.9458 | 34.5651 | 39.4094 |
Total Common Shares Outstanding | 51.9741 | 48.106 | 48.0203 | 47.8983 | 47.8797 |
Other Equity, Total |
- Anual
- Trimestral
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Ingresos netos/Línea de salida | -23.7406 | -19.5956 | -17.9428 | -10.6548 | -12.3723 |
Efectivo de actividades de explotación | -17.779 | -14.2849 | -13.9351 | -6.91872 | -6.84653 |
Efectivo de actividades de explotación | 0.02558 | 0.02253 | 0.02278 | 0.01307 | 0.00589 |
Partidas no monetarias | 4.73194 | 4.27821 | 4.24619 | 3.52998 | 5.43538 |
Cambios en el capital circulante | 1.20414 | 1.00995 | -0.26128 | 0.19299 | 0.08454 |
Efectivo de actividades de inversión | 0.09773 | -0.0838 | -2.33725 | -0.9469 | -0.10332 |
Gastos de capital | -0.05974 | -0.07244 | -0.12799 | -0.14512 | -0.10332 |
Efectivo procedente de actividades de financiación | 0.00643 | 25.6779 | 41.5895 | 1.26719 | 15.3895 |
Emisión (retiro) de acciones, neto | 0.00643 | 25.6779 | 41.5895 | 1.26719 | 15.3895 |
Variación neta de la tesorería | -17.6748 | 11.3092 | 25.3172 | -6.59843 | 8.43967 |
Otras partidas de flujo de caja de inversión, total | 0.15747 | -0.01136 | -2.20926 | -0.80178 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -9.20277 | -23.7406 | -16.9746 | -10.8918 | -5.30982 |
Cash From Operating Activities | -6.93244 | -17.779 | -13.1926 | -8.62165 | -4.0717 |
Cash From Operating Activities | 0.00402 | 0.02558 | 0.0195 | 0.01327 | 0.00673 |
Non-Cash Items | 1.33212 | 4.73194 | 3.18436 | 2.0261 | 1.05744 |
Cash Taxes Paid | |||||
Cash Interest Paid | |||||
Changes in Working Capital | 0.93421 | 1.20414 | 0.57811 | 0.23078 | 0.17395 |
Cash From Investing Activities | -0.01963 | 0.09773 | 0.07805 | 0.0458 | -0.00184 |
Capital Expenditures | -0.01963 | -0.05974 | -0.03974 | -0.02369 | -0.00184 |
Other Investing Cash Flow Items, Total | 0.15747 | 0.11779 | 0.06949 | ||
Cash From Financing Activities | 4.08078 | 0.00643 | 0.00175 | 0 | 0 |
Issuance (Retirement) of Stock, Net | 4.08078 | 0.00643 | 0.00175 | 0 | |
Net Change in Cash | -2.87128 | -17.6748 | -13.1128 | -8.57586 | -4.07354 |
Financing Cash Flow Items | 0 |
Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
---|---|---|---|---|---|---|
Armistice Capital LLC | Hedge Fund | 3.7515 | 1950000 | 1950000 | 2023-03-31 | HIGH |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.5141 | 1826600 | 0 | 2023-03-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.0759 | 559235 | 3612 | 2023-03-31 | LOW |
Varner (John Rodney) | Individual Investor | 1.0688 | 555535 | -606000 | 2023-04-25 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8604 | 447211 | 15074 | 2023-03-31 | LOW |
Berger (Mark Stanley) | Individual Investor | 0.4713 | 245000 | 245000 | 2023-02-18 | |
Kumar (Hermant) | Individual Investor | 0.3848 | 200000 | 200000 | 2023-02-18 | |
Confer (Ryan M.) | Individual Investor | 0.3665 | 190499 | -245000 | 2023-04-25 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.3317 | 172439 | 42700 | 2023-03-31 | LOW |
Rockefeller Capital Management | Investment Advisor | 0.2886 | 150000 | 150000 | 2023-03-31 | LOW |
Group One Trading, L.P. | Research Firm | 0.2021 | 105067 | 44713 | 2023-03-31 | HIGH |
IHT Wealth Management, LLC | Investment Advisor | 0.1585 | 82372 | 29997 | 2023-03-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1575 | 81861 | -4569 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.1486 | 77219 | 77219 | 2023-03-31 | HIGH |
Silvercrest Asset Management Group LLC | Investment Advisor/Hedge Fund | 0.1077 | 56000 | 0 | 2023-03-31 | LOW |
Verus Capital Partners, LLC | Investment Advisor | 0.1068 | 55500 | -33000 | 2023-03-31 | MED |
Renaissance Technologies LLC | Hedge Fund | 0.0987 | 51307 | -3593 | 2023-03-31 | HIGH |
Staley Capital Advisers, Inc. | Hedge Fund | 0.0962 | 50000 | 0 | 2023-03-31 | LOW |
StoneX Group Inc. | Research Firm | 0.0676 | 35150 | 0 | 2023-03-31 | HIGH |
Longnecker (Brent M) | Individual Investor | 0.0673 | 35000 | 0 | 2023-04-25 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group530K+
Traders
87K+
Clientes activos mensualmente
$46M+
Volumen mensual de inversión
$31M+
Retiros por mes
Calculadora de trading
Calcula tus P&L hipotéticas en el supuesto de haber abierto una operación con CFD en una fecha determinada (selecciona una fecha) y haberla cerrado en otra fecha (selecciona una fecha).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Genprex, Inc. Company profile
Sobre Genprex Inc
Genprex, Inc. es una empresa de terapia génica en fase clínica centrada en el desarrollo de tratamientos para el cáncer y la diabetes. El principal candidato a fármaco contra el cáncer de la empresa, el medicamento de inmunoterapia REQORSA (también denominado GPX-001), se está desarrollando para tratar el cáncer de pulmón de células no pequeñas (CPCNP). El agente activo de REQORSA es un plásmido que expresa el gen TUSC2 y está encapsulado en una nanopartícula de colesterol DOTAP. TUSC2 es un gen supresor de tumores que tiene efectos tanto de eliminación de tumores (vía apoptosis) como de inmunomodulación. La empresa utiliza su sistema de administración de nanopartículas ONCOPREX para administrar el plásmido que expresa el gen TUSC2 a las células cancerosas. Su terapia génica para la diabetes, también denominada GPX-002, está diseñada para actuar transformando las células alfa del páncreas en células funcionales de tipo beta, que pueden producir insulina pero son lo suficientemente distintas de las células beta como para eludir el sistema inmunitario del organismo.
El precio actual de la acción Genprex, Inc. en tiempo real es 0.8013 USD. El gráfico de la acción permite a los inversores comprender mejor el rendimiento y el precio de la acción y tomar decisiones informadas al negociar acciones y CFD.
Descubra más acciones con gráficos, datos vitales y actualizaciones de precios en tiempo real: Brainstorm Cell Therapeutics Inc., Lifetime Brands, Baillie Gifford Japan Trust PLC, SurModics, ZoomInfo Technologies Inc. y Vor Biopharma Inc.. Para obtener más información, consulte los perfiles de las empresas en Capital.com.
Industry: | Bio Therapeutic Drugs |
Suite 3.322
1601 Trinity Street, Bldg. B
AUSTIN
TEXAS 78712
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 530.000 traders de todo el mundo que eligen operar con Capital.com